Pulsenmore Ltd Ordinary Shares (PLSM) | Q4 2025 | 703.15% |
Charming Medical Limited Class A Ordinary Shares (MCTA) | Q4 2025 | 539.54% |
Damora Therapeutics (DMRA) | Q4 2025 | 532.14% |
Aimei Health Technology Co, Ltd Ordinary Share (AFJK) | Q4 2025 | 464.71% |
Praxis Precision Medicines (PRAX) | Q4 2025 | 458.85% |
WeShop Holdings Limited Class A Ordinary Shares (WSHP) | Q4 2025 | 374.53% |
Alto Neuroscience (ANRO) | Q4 2025 | 345% |
Omeros (OMER) | Q4 2025 | 318.9% |
MMTEC (MTC) | Q4 2025 | 300.47% |
Capricor Therapeutics (CAPR) | Q4 2025 | 300.28% |
Hycroft Mining (HYMC) | Q4 2025 | 277.9% |
AXT (AXTI) | Q4 2025 | 264.14% |
T1 Energy (TE) | Q4 2025 | 207.83% |
Sidus Space (SIDU) | Q4 2025 | 201.92% |
PACS (PACS) | Q4 2025 | 183.32% |
Rani Therapeutics (RANI) | Q4 2025 | 181.25% |
Alto Ingredients (ALTO) | Q4 2025 | 174.29% |
Lipocine (LPCN) | Q4 2025 | 174.06% |
Roadzen (RDZN) | Q4 2025 | 171.09% |
Ironwood Pharmaceuticals (IRWD) | Q4 2025 | 161.24% |
TryHard Holdings Limited Ordinary Shares (THH) | Q4 2025 | 159.21% |
Agencia Comercial Spirits Ltd Class A Ordinary Shares (AGCC) | Q4 2025 | 155.5% |
Olema Pharmaceuticals (OLMA) | Q4 2025 | 153.55% |
Immix Biopharma (IMMX) | Q4 2025 | 152.66% |
9F (JFU) | Q4 2025 | 152.37% |
